首页> BMC cancer> Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis.

Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis.

导出 OA

翻译打印收藏纠错

第一作者： Lingli,Luo

第一单位： Medical College, Hunan Polytechnic of Environment and Biology, Hunan Province, 421005, Hengyang, China.

作者： Lingli,Luo ^[1] ; Xiangru,Shen ^[2] ; Shuai,Fang ^[2] ; Teng,Wan ^[3] ; Pan,Liu ^[2] ; Peiling,Li ^[2] ; Haifeng,Tan ^[2] ; Yong,Fu ^[4] ; Weiming,Guo ^[5] ; Xiaojun,Tang ^[6]

作者单位： Medical College, Hunan Polytechnic of Environment and Biology, Hunan Province, 421005, Hengyang, China. ^[1] Hengyang Medical College, University of South China, Hunan, 421001, Hengyang, China. ^[2] Department of Neurology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, 518060, China. ^[3] Department of Trauma Orthopaedic, The Second Affiliated Hospital, Hengyang Medical College, University of South China, Hengyang, 421001, Hunan, China. ^[4] Department of Sports Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, 518060, China. ^[5] The Second Affiliated Hospital, Department of Spinal Surgery, Hengyang Medical School, University of South China, Hunan, 421001, Hengyang, China. medictxj@usc.edu.cn. ^[6]

关键词 Meta Metastases Progression-free survival Retrospective study Sarcopenia

医学主题词人类(Humans);肌减少症(Sarcopenia);回顾性研究(Retrospective Studies);危险因素(Risk Factors)

DOI 10.1186/s12885-023-10582-2

PMID 36750774

发布时间 2023-02-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交